Enveda
Enveda discovers medicines by studying the chemistry of nature and translating natural compounds into potential therapeutic candidates. The company combines computational methods, analytical chemistry, biology, and machine learning to identify molecules, understand their biological activity, and support drug discovery. Its platform examines complex natural mixtures to determine molecular structures and their effects on biological systems. Enveda also develops a pipeline of drug candidates targeting areas of human health and provides research capabilities focused on discovering and developing medicines derived from natural sources.
Funding
Every round, secondary, debt facility or acquisition involving Enveda that AI Lounge tracks, newest first. Latest: Series E on Sep 23, 2026.
Timeline · 2
In the news
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in